Fluorine in PDB 4zji: PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
Enzymatic activity of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
All present enzymatic activity of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine:
2.7.11.1;
Protein crystallography data
The structure of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine, PDB code: 4zji
was solved by
S.Gutmann,
G.Rummel,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
81.81 /
1.99
|
Space group
|
P 21 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
110.520,
115.060,
116.360,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
19.1 /
22
|
Other elements in 4zji:
The structure of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
(pdb code 4zji). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine, PDB code: 4zji:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 4zji
Go back to
Fluorine Binding Sites List in 4zji
Fluorine binding site 1 out
of 4 in the PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F601
b:23.1
occ:1.00
|
F
|
A:4OQ601
|
0.0
|
23.1
|
1.0
|
C5
|
A:4OQ601
|
1.4
|
25.6
|
1.0
|
C6
|
A:4OQ601
|
2.3
|
23.9
|
1.0
|
C4
|
A:4OQ601
|
2.3
|
23.3
|
1.0
|
NE2
|
A:HIS387
|
3.1
|
19.4
|
1.0
|
CD2
|
A:HIS387
|
3.1
|
19.1
|
1.0
|
C
|
A:THR406
|
3.2
|
20.7
|
1.0
|
O
|
A:THR406
|
3.3
|
19.7
|
1.0
|
CG
|
A:LEU405
|
3.5
|
23.3
|
1.0
|
C3
|
A:4OQ601
|
3.6
|
21.8
|
1.0
|
C7
|
A:4OQ601
|
3.6
|
23.6
|
1.0
|
N
|
A:ASP407
|
3.6
|
18.0
|
1.0
|
CB
|
A:ASP407
|
3.7
|
19.7
|
1.0
|
CA
|
A:THR406
|
3.7
|
17.5
|
1.0
|
N
|
A:THR406
|
3.8
|
17.9
|
1.0
|
O
|
A:LEU405
|
3.9
|
20.8
|
1.0
|
C
|
A:LEU405
|
3.9
|
22.0
|
1.0
|
CD2
|
A:LEU405
|
4.0
|
22.5
|
1.0
|
C2
|
A:4OQ601
|
4.1
|
21.6
|
1.0
|
CA
|
A:ASP407
|
4.1
|
18.3
|
1.0
|
CB
|
A:LEU405
|
4.3
|
18.7
|
1.0
|
CD1
|
A:LEU405
|
4.3
|
23.4
|
1.0
|
CD1
|
A:LEU380
|
4.4
|
20.1
|
1.0
|
CE1
|
A:HIS387
|
4.4
|
19.1
|
1.0
|
CG
|
A:HIS387
|
4.4
|
18.7
|
1.0
|
N1
|
A:4OQ601
|
4.7
|
23.7
|
1.0
|
CA
|
A:LEU405
|
4.8
|
18.5
|
1.0
|
O
|
A:HOH861
|
4.8
|
23.8
|
1.0
|
CG
|
A:ASP407
|
4.9
|
21.9
|
1.0
|
CG2
|
A:ILE327
|
5.0
|
19.1
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 4zji
Go back to
Fluorine Binding Sites List in 4zji
Fluorine binding site 2 out
of 4 in the PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F601
b:30.4
occ:1.00
|
F
|
B:4OQ601
|
0.0
|
30.4
|
1.0
|
C5
|
B:4OQ601
|
1.4
|
30.4
|
1.0
|
C6
|
B:4OQ601
|
2.3
|
29.7
|
1.0
|
C4
|
B:4OQ601
|
2.4
|
28.9
|
1.0
|
NE2
|
B:HIS387
|
3.1
|
22.5
|
1.0
|
CD2
|
B:HIS387
|
3.1
|
22.8
|
1.0
|
C
|
B:THR406
|
3.2
|
25.5
|
1.0
|
O
|
B:THR406
|
3.3
|
24.7
|
1.0
|
N
|
B:ASP407
|
3.6
|
21.6
|
1.0
|
CG
|
B:LEU405
|
3.6
|
28.4
|
1.0
|
C3
|
B:4OQ601
|
3.6
|
28.9
|
1.0
|
C7
|
B:4OQ601
|
3.6
|
30.5
|
1.0
|
CB
|
B:ASP407
|
3.6
|
24.0
|
1.0
|
CA
|
B:THR406
|
3.7
|
23.2
|
1.0
|
N
|
B:THR406
|
3.9
|
23.1
|
1.0
|
O
|
B:LEU405
|
3.9
|
26.2
|
1.0
|
C
|
B:LEU405
|
3.9
|
26.7
|
1.0
|
CD2
|
B:LEU405
|
4.1
|
27.7
|
1.0
|
CA
|
B:ASP407
|
4.1
|
22.1
|
1.0
|
C2
|
B:4OQ601
|
4.1
|
29.6
|
1.0
|
CD1
|
B:LEU380
|
4.4
|
24.5
|
1.0
|
CE1
|
B:HIS387
|
4.4
|
21.8
|
1.0
|
CD1
|
B:LEU405
|
4.4
|
27.6
|
1.0
|
CB
|
B:LEU405
|
4.4
|
23.7
|
1.0
|
CG
|
B:HIS387
|
4.4
|
21.9
|
1.0
|
N1
|
B:4OQ601
|
4.7
|
29.0
|
1.0
|
O
|
B:HOH826
|
4.8
|
29.0
|
1.0
|
CA
|
B:LEU405
|
4.8
|
23.4
|
1.0
|
CG
|
B:ASP407
|
4.9
|
26.3
|
1.0
|
CG2
|
B:ILE327
|
5.0
|
28.6
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 4zji
Go back to
Fluorine Binding Sites List in 4zji
Fluorine binding site 3 out
of 4 in the PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F601
b:28.7
occ:1.00
|
F
|
C:4OQ601
|
0.0
|
28.7
|
1.0
|
C5
|
C:4OQ601
|
1.4
|
29.2
|
1.0
|
C4
|
C:4OQ601
|
2.3
|
29.1
|
1.0
|
C6
|
C:4OQ601
|
2.3
|
28.0
|
1.0
|
NE2
|
C:HIS387
|
3.1
|
25.5
|
1.0
|
CD2
|
C:HIS387
|
3.1
|
25.8
|
1.0
|
O
|
C:THR406
|
3.2
|
25.2
|
1.0
|
C
|
C:THR406
|
3.2
|
26.8
|
1.0
|
CG
|
C:LEU405
|
3.6
|
28.0
|
1.0
|
C3
|
C:4OQ601
|
3.6
|
27.4
|
1.0
|
N
|
C:ASP407
|
3.6
|
27.0
|
1.0
|
C7
|
C:4OQ601
|
3.6
|
31.2
|
1.0
|
CA
|
C:THR406
|
3.8
|
23.4
|
1.0
|
CB
|
C:ASP407
|
3.8
|
30.6
|
1.0
|
O
|
C:LEU405
|
3.9
|
25.0
|
1.0
|
N
|
C:THR406
|
3.9
|
22.7
|
1.0
|
C
|
C:LEU405
|
3.9
|
26.7
|
1.0
|
CD2
|
C:LEU405
|
4.0
|
28.0
|
1.0
|
C2
|
C:4OQ601
|
4.1
|
28.0
|
1.0
|
CA
|
C:ASP407
|
4.1
|
28.4
|
1.0
|
CD1
|
C:LEU380
|
4.3
|
25.4
|
1.0
|
CE1
|
C:HIS387
|
4.4
|
25.2
|
1.0
|
CB
|
C:LEU405
|
4.4
|
23.4
|
1.0
|
CD1
|
C:LEU405
|
4.4
|
27.9
|
1.0
|
CG
|
C:HIS387
|
4.4
|
24.4
|
1.0
|
N1
|
C:4OQ601
|
4.7
|
30.6
|
1.0
|
CA
|
C:LEU405
|
4.8
|
22.9
|
1.0
|
O
|
C:HOH825
|
4.8
|
34.8
|
1.0
|
CG2
|
C:ILE327
|
4.9
|
24.9
|
1.0
|
CG
|
C:ASP407
|
4.9
|
40.1
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 4zji
Go back to
Fluorine Binding Sites List in 4zji
Fluorine binding site 4 out
of 4 in the PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of PAK1 in Complex with 2-Chloro-5-Ethyl-8-Fluoro-11-(4-Methylpiperazin- 1-Yl)-Dibenzodiazepine within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F601
b:26.8
occ:1.00
|
F
|
D:4OQ601
|
0.0
|
26.8
|
1.0
|
C5
|
D:4OQ601
|
1.4
|
27.1
|
1.0
|
C4
|
D:4OQ601
|
2.3
|
26.6
|
1.0
|
C6
|
D:4OQ601
|
2.3
|
25.1
|
1.0
|
CD2
|
D:HIS387
|
3.1
|
25.4
|
1.0
|
NE2
|
D:HIS387
|
3.1
|
25.0
|
1.0
|
O
|
D:THR406
|
3.3
|
22.7
|
1.0
|
C
|
D:THR406
|
3.3
|
26.4
|
1.0
|
CG
|
D:LEU405
|
3.6
|
24.0
|
1.0
|
C3
|
D:4OQ601
|
3.6
|
26.3
|
1.0
|
C7
|
D:4OQ601
|
3.6
|
27.6
|
1.0
|
N
|
D:ASP407
|
3.7
|
26.0
|
1.0
|
CB
|
D:ASP407
|
3.7
|
29.2
|
1.0
|
CA
|
D:THR406
|
3.8
|
23.3
|
1.0
|
O
|
D:LEU405
|
4.0
|
23.3
|
1.0
|
N
|
D:THR406
|
4.0
|
22.8
|
1.0
|
CD2
|
D:LEU405
|
4.0
|
24.3
|
1.0
|
C
|
D:LEU405
|
4.0
|
24.9
|
1.0
|
C2
|
D:4OQ601
|
4.1
|
25.6
|
1.0
|
CD1
|
D:LEU380
|
4.2
|
18.2
|
1.0
|
CA
|
D:ASP407
|
4.2
|
27.0
|
1.0
|
CE1
|
D:HIS387
|
4.4
|
24.7
|
1.0
|
CB
|
D:LEU405
|
4.4
|
20.0
|
1.0
|
CG
|
D:HIS387
|
4.4
|
24.1
|
1.0
|
CD1
|
D:LEU405
|
4.4
|
23.2
|
1.0
|
N1
|
D:4OQ601
|
4.7
|
26.1
|
1.0
|
CG2
|
D:ILE327
|
4.8
|
20.7
|
1.0
|
CA
|
D:LEU405
|
4.9
|
20.1
|
1.0
|
CG
|
D:ASP407
|
4.9
|
36.4
|
1.0
|
O
|
D:HOH851
|
4.9
|
31.3
|
1.0
|
|
Reference:
A.S.Karpov,
P.Amiri,
C.Bellamacina,
M.H.Bellance,
W.Breitenstein,
D.Daniel,
R.Denay,
D.Fabbro,
C.Fernandez,
I.Galuba,
S.Guerro-Lagasse,
S.Gutmann,
L.Hinh,
W.Jahnke,
J.Klopp,
A.Lai,
M.K.Lindvall,
S.Ma,
H.Mobitz,
S.Pecchi,
G.Rummel,
K.Shoemaker,
J.Trappe,
C.Voliva,
S.W.Cowan-Jacob,
A.L.Marzinzik.
Optimization of A Dibenzodiazepine Hit to A Potent and Selective Allosteric PAK1 Inhibitor. Acs Med.Chem.Lett. V. 6 776 2015.
ISSN: ISSN 1948-5875
PubMed: 26191365
DOI: 10.1021/ACSMEDCHEMLETT.5B00102
Page generated: Thu Aug 1 07:18:20 2024
|